Top Markets
#1 Siren Siren +33.52%
#2 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +23.74%
#3 Wiki Cat Wiki Cat +18.30%
#4 Ribbita by Virtuals Ribbita by Virtuals +17.99%
#5 Velvet Velvet +17.05%
#6 PulseChain PulseChain +16.92%
#7 Bitway Bitway +16.47%
#8 TRIA TRIA +15.91%
#9 Wrapped Bitcoin (PulseChain) Wrapped Bitcoin (PulseChain) +15.66%
#10 Cysic Cysic +15.23%
Coin of the day
Siren Siren
Settings
Language
ENGLISH
Currency
USD
Theme
Pharmala Biotech Holdings Inc. Pharmala Biotech Holdings Inc.

Pharmala Biotech Holdings Inc.

MDMA
Rank in Stocks #30975
Pharmala Biotech Holdings Inc., operating as PharmAla, concentrates its efforts... Pharmala Biotech Holdings Inc., operating as PharmAla, concentrates its efforts on the research, manufacturing, and bringing to market of active pharmaceutical ingredients (APIs) within the substituted methylenedioxy-phenethylamine (MDXX) class. The company's offerings further extend to various MDXX class compounds, such as 1,3-Benzodioxolyl-Nmethylbutanamine (MBDB) and 3,4-Methylenedioxy-N-ethylamphetamine (MDEA/MDE), in addition to prepared formulations of these MDXX substances. The enterprise maintains its primary corporate offices in Vancouver, Canada.
Share Price
$0.13577832
Market Cap
$14.83M
Change (1 day)
-2.63%
Change (1 year)
44.13%
Country
CA
Trade Pharmala Biotech Holdings Inc. (MDMA)

Category

Healthcare
Number of shares outstanding for Pharmala Biotech Holdings Inc. (MDMA)
Number of shares outstanding as of August 2026: 0
According to Pharmala Biotech Holdings Inc. latest financial reports and stock price the company's current number of shares outstanding is 0. At the end of August 2026 the company had 0 shares outstanding. The number of outstanding shares is usually impacted by stock plits and shares buy back.
Shares outstanding history for Pharmala Biotech Holdings Inc. (MDMA) from 2026 to 2026
Shares Outstanding at the end of each year
Year Shares Outstanding Change
Not enough data for the provided dates.
Shares Outstanding for similar companies or competitors
Company Shares Outstanding Difference Country
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 253.90M -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 62.19M -
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
 483.58M -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 0.00 -
BE